<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00353743</url>
  </required_header>
  <id_info>
    <org_study_id>05-452</org_study_id>
    <secondary_id>GPPG 05-452</secondary_id>
    <nct_id>NCT00353743</nct_id>
  </id_info>
  <brief_title>The Use of Antibiotics After Hospital Discharge in Septic Abortion</brief_title>
  <acronym>APA</acronym>
  <official_title>A Randomized Clinical Trial on the Use or Not of Antibiotics After Hospital Discharge in Septic Abortion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of antibiotics in post-partum infection has been abbreviated. After 48 hours of&#xD;
      clinical improvement, the patient is discharged from the hospital without antibiotics. No&#xD;
      trials has been found in cases of septic abortion.&#xD;
&#xD;
      The purpose of the present study is to verify the need of antibiotics after clinical&#xD;
      improvement in cases of septic abortion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic abortion is still a major cause of maternal mortality in developing countries.&#xD;
      According to the WHO, 1 woman dies for every 270 illegal abortion (Ahman E, 2004). Infected&#xD;
      abortion has an important role in maternal morbidity and mortality (Stubblefield PG, 1994).&#xD;
      the diagnosis of infected abortion must be considered when a patient presents a history of&#xD;
      delayed menses, vaginal bleeding, abdominal pain and fever (Brasil, 2000)&#xD;
&#xD;
      Prompt diagnosis and treatment are paramount steps to prevent complications. At Hospital de&#xD;
      Clínicas de Porto Alegre, the use of gentamycin plus clindamicin before curettage is&#xD;
      preconized (Savaris R, 2006). Nevertheless, the time of treatment it is not well established,&#xD;
      varying from 7-14 days (Brasil, 2000).&#xD;
&#xD;
      A recent study with post-partum endometritis has shown that it is not necessary to extend the&#xD;
      treatment to 14 days, after clinical improvement (Turnquest MA, 1998; French LM, 2004)&#xD;
&#xD;
      A randomized clinical trial comparing placebo with the standard protocol of treatment would&#xD;
      define weather both treatments are equivalent or not.&#xD;
&#xD;
      Comparison: The prolonged use of antibiotics, after intravenous use of antibiotics and&#xD;
      clinical improvement, will be compared to the use of placebo in cases of septic abortion.&#xD;
&#xD;
      Sample size and ethical issues The study protocol was approved by the ethics committee of&#xD;
      Hospital de Clínicas de Porto Alegre.&#xD;
&#xD;
      To compare equivalence between the 2 treatments we calculated the sample size considering an&#xD;
      alpha error of 0.05, a beta error of 0.1, and difference between the two groups of no more&#xD;
      than 10%. We expected a 99% clinical cure with the standard protocol, and 95% for the&#xD;
      alternative one. These figures yield a minimum of 42 patients in each group. Interim analysis&#xD;
      will performed at 58 for possible early stopping, if clinical cure was &lt; 95%, or for sample&#xD;
      size re-estimation.&#xD;
&#xD;
      Randomization and treatment Subjects will be allocated in blocks of four at a time to create&#xD;
      the allocation sequence. If the patient was eligible for the study, she will be allocated to&#xD;
      one of the 2 treatments. The allocation will be concealed, coded and obtained from a central&#xD;
      telephone number. Patients and those who assessed the outcomes were blind to group&#xD;
      assignment. To avoid bias, both medications were manipulated by the hospital pharmacy and put&#xD;
      in identically coded blisters and capsules.&#xD;
&#xD;
      Statistical analysis Student´s t-test, Mann-Whitney test, and Fisher´s exact test will be&#xD;
      used for statistical analysis. The rates of cure were analyzed by &quot;modified&quot; intention to&#xD;
      treat (Keech AC, 2003) and per protocol with 95% confidence intervals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Rate of cure was higher than expected, IRB suspended for no additional benefit&#xD;
  </why_stopped>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical cure defined as no fever, no abdominal pain or bleeding.</measure>
    <time_frame>10 days after hospital discharge</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Abortion, Septic</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients that receive up to 10 days of doxycycline 200mg/day and metronidazole 500mg/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients that do not receive antibiotics, only placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>doxycycline plus metronidazole</intervention_name>
    <description>doxycycline 200mg/day plus metronidazole 500mg/day up to 10 days of treatment (additional to the hospital treatment)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Vibramicina</other_name>
    <other_name>Flagyl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted at the hospital with a diagnosis of infected abortion and about to&#xD;
             be discharged from the hospital.&#xD;
&#xD;
          -  Use of intravenous antibiotics (gentamicin and clindamycin)&#xD;
&#xD;
          -  Improvement of the clinical conditions for at least 48 hours (no fever, eating and&#xD;
             walking normally, reduced vaginal bleeding)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling to participate in the study.&#xD;
&#xD;
          -  Use of antibiotics previously within one week.&#xD;
&#xD;
          -  Presence of tubo-ovarian abscess.&#xD;
&#xD;
          -  Known allergy to doxycycline or metronidazole.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo F Savaris, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Clínias de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90035-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Ahman E, Shah I. Unsafe abortion: worldwide estimates for 2000. Reprod Health Matters. 2002 May;10(19):13-7.</citation>
    <PMID>12369316</PMID>
  </reference>
  <reference>
    <citation>Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med. 1994 Aug 4;331(5):310-4. Review.</citation>
    <PMID>8022443</PMID>
  </reference>
  <reference>
    <citation>Brasil.Ministério da Saúde. Abortamento infectado. In: Ministério da Saúde, ed. Urgências e emergências maternas: guia para diagnóstico e conduta em situações de risco de morte materna. 1 ed. Brasília: MS/FEBRASGO; 2000: 13-17.</citation>
  </reference>
  <reference>
    <citation>Savaris R. Abortamento. In: Freitas FM, Costa SMH, Lopes JG, eds. Rotinas em Obstetrícia. 5 ed. Porto Alegre: Artmed; 2006: 70-77.</citation>
  </reference>
  <reference>
    <citation>Turnquest MA, How HY, Cook CR, O'Rourke TP, Cureton AC, Spinnato JA, Brown HL. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol. 1998 Nov;179(5):1261-6.</citation>
    <PMID>9822512</PMID>
  </reference>
  <reference>
    <citation>French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001067. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD001067.</citation>
    <PMID>15495005</PMID>
  </reference>
  <reference>
    <citation>Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust. 2003 Oct 20;179(8):438-40. Review.</citation>
    <PMID>14558871</PMID>
  </reference>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>July 13, 2006</study_first_submitted>
  <study_first_submitted_qc>July 17, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2006</study_first_posted>
  <last_update_submitted>December 18, 2008</last_update_submitted>
  <last_update_submitted_qc>December 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ricardo Francalacci Savaris</name_title>
    <organization>HCPA-UFRGS</organization>
  </responsible_party>
  <keyword>infected abortion</keyword>
  <keyword>treatment period</keyword>
  <keyword>doxycycline</keyword>
  <keyword>metronidazole</keyword>
  <keyword>placebo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Doxycycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

